fluticasone propionate/salmeterol xinafoate combination

DRUG3 trials

Sponsors

GlaxoSmithKline

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Unknown Phase

Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies

CompletedNCT01332461

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2009-11-30End: 2010-05-31Updated: 2017-06-27

Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy

CompletedNCT01347060

GlaxoSmithKlineAsthma

Start: 2009-07-31End: 2010-04-30Updated: 2017-05-25

Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT01381471

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2009-08-31End: 2010-05-31Updated: 2012-03-29